Mounjaro Injectable Pen
  1. Home
  2. Mounjaro
  3. Mounjaro Injectable Pen

Mounjaro Injectable Pen

Mounjaro Injectable Pen is a prescription dual GIP and GLP-1 receptor agonist prefilled injection pen used to improve glycemic control in adults with type 2 diabetes and, for certain formulations, to support chronic weight management. It is designed for convenient once-weekly subcutaneous administration with accurate dose delivery. The injectable pen provides reliable and user-friendly medication administration.

BUY NOW

Category

Mounjaro Injectable Pen contains tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that helps regulate blood glucose by enhancing glucose-dependent insulin secretion, reducing glucagon release, slowing gastric emptying, and promoting satiety. The prefilled injection pen is engineered for precise subcutaneous administration, offering consistent once-weekly dosing and dependable therapeutic performance across the prescribed treatment period. Manufactured under stringent pharmaceutical quality standards, the sterile pen is available in multiple dosage strengths to meet individual treatment requirements while ensuring reliable clinical performance. Mounjaro Injectable Pen should be used only under the supervision of a qualified healthcare professional according to the prescribed treatment plan.

Technical Specification

Specification Details
Product Name Mounjaro Injectable Pen
Active Ingredient Tirzepatide
Dosage Form Prefilled Injection Pen
Route of Administration Subcutaneous Injection
Dosing Frequency Once Weekly (As Prescribed)
Storage Refrigerate at 2°C–8°C before first use

Product Also Known As

Mounjaro Injectable Pen, Mounjaro Injection Pen, Tirzepatide Injectable Pen, Tirzepatide Prefilled Pen, Weekly Tirzepatide Injection, GIP GLP-1 Injection Pen, Diabetes Injection Pen